Biotech Startups

Gelatex Technologies develops nanofiber production technology for use in food production, medical applications, and sustainable materials. The company focuses on creating materials with lower environmental impact across multiple industrial sectors.

3 investors

GelMEDIX is a Cambridge-based biotech developing injectable hydrogel-based cell and gene therapies for vision-restoring retinal treatment.

3 investors

Gencove provides direct-to-consumer genetic sequencing and polygenic risk scoring for health insights. The service analyzes DNA samples to deliver personalized health recommendations across core health areas, ancestry information, and integrates with labs, wearables, and lifestyle data.

3 investors

Skyline Therapeutics develops gene therapy vector technology and supports clinical development for therapeutic applications using genetic science approaches.

3 investors

Genenta Science is a clinical-stage biotechnology company developing Temferon, a hematopoietic stem cell-based gene therapy platform for treating cancer. The company is publicly traded on Nasdaq under the ticker GNTA.

3 investors

3 investors

GenHealth provides AI-based revenue cycle management and administrative automation for healthcare providers and DME teams, handling intake, eligibility, claims, prior authorization, denials, and appeals. Its browser agent extracts data from faxes and documents and routes it into EMR and billing systems, targeting independent physician groups and providers.

3 investors

Genialis is a precision oncology company that applies data analysis to help drug developers understand mechanisms of action, resistance, and patient stratification for cancer therapies. It supports pharmaceutical partners in advancing molecules through clinical trials toward becoming effective medicines.

3 investors

Genica develops biological agricultural inputs (bioinsumos) such as biofertilizers, biological fungicides, and nematicides based on microorganisms and organic molecules to improve crop productivity. The company uses bioprospecting, molecular techniques, and bioinformatics to create products for farmers, serving the agriculture sector in Brazil.

3 investors

Genie Fertility develops a discovery platform that uses machine learning and multi-omics analysis to identify molecular biomarkers in uterine lining, leveraging menstrual blood samples to improve reproductive health outcomes and fertility diagnostics. The platform aims to address the high failure rate of IVF by providing better understanding of endometrial health, which can account for up to one-quarter of infertility issues.

3 investors

Geninus develops IntelliMed, a platform that uses multimodal spatial transcriptomics and patient data to discover novel drug targets for oncology, particularly for modalities like TCEs and ADCs. The platform combines spatial genomics, protein profiling, and clinical outcomes to enable target discovery with reduced biological risk.

3 investors

Genkyotex was a developer of NOX inhibitor therapeutics, now owned by Calliditas Therapeutics AB.

3 investors

Uses a T-cell antigen discovery platform to develop vaccines for oncology and infectious disease.

3 investors

Genomatica (Geno) develops biotechnology processes to produce bio-based chemicals and materials—such as 1,4-butanediol (BDO), butylene glycol for cosmetics, and plant-based nylon—as alternatives to fossil-fuel-derived inputs. It licenses and scales these technologies with industrial partners across the chemicals, beauty, and materials industries in the US, Europe, and Asia.

3 investors

Genomic Health develops diagnostic tests and related services and runs health-equity initiatives aimed at improving access, awareness, and outcomes for patients and communities, including uninsured and underinsured populations. The company focuses on making its tests inclusive through diverse clinical trials, patient education, and community partnerships.

3 investors

LifeView, operated by Genomic Prediction, offers preimplantation genetic testing (PGT) for IVF embryos, including screening for aneuploidy, monogenic disorders, structural rearrangements, and polygenic disease risk. Its tests serve fertility clinics and IVF patients to help select embryos for transfer.

3 investors

Genvax Technologies develops mRNA and nanoparticle-based vaccines for livestock, focusing on custom, herd-specific formulations that aim to improve speed and precision compared to conventional vaccine platforms. The company serves animal health and food supply sectors.

3 investors

Geron is a biopharmaceutical company focused on developing therapies for blood cancer. The company has over 30 years of experience in research and clinical development.

3 investors

Giftshed builds a single-cell cancer data platform that images billions of cells from whole blood, uses Vision AI and robotics to detect and isolate rare circulating tumor cells, and applies single-cell RNA sequencing and multi-omics to guide precision cancer therapy. The platform is aimed at personalized cancer diagnostics and metastatic biology research.

3 investors

Gilead is a biopharmaceutical company that develops medicines across virology, oncology, and inflammation, with over 25 medicines offered globally and 53 clinical programs. It also funds philanthropic HIV programs in the U.S. and works to advance health equity.

3 investors

Baltimore-based immunology company focused on treatments for cancer and autoimmune disorders; raised an $11.5 million Series C led by First In Ventures.

3 investors

GlycosBio conducts research and development using engineered lipid technologies to improve the bioavailability and therapeutic performance of natural bioactive molecules, including approaches targeting the intestinal, pulmonary, and skin microbiota. It works with clients on collaborative R&D, clinical validation, and IP licensing of its patented technologies, with research based at the Texas Medical Center in Houston.

3 investors

Cambridge, MA biotechnology company developing injectable synthetic biomarkers for noninvasive disease staging and treatment monitoring.

3 investors

A pharmaceutical company that markets a portfolio of drug products across various dosage forms, with labeling and packaging following FDA requirements. Its products and prescribing information are registered under labeler codes 60429 and 51407 and listed on DailyMed.

3 investors